UNSPSC 51182423: Ibandronate or ibandronic acid

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C9H23NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UMD7G2653W, chemically known as phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- but generally known as ibandronic acid, which bears US NIH Compound Identifier 60852. European Medicines Agency schedules Ibandronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08092MIG.

UNSPSC 51182423 Ibandronate or ibandronic acid is a Commodity code that in recent state and local procurement shows a significant mismatch between its nominal scope and actual buying activity. The single recent opportunity on record is Collin County Community Supervision and Corrections Department RFP 2026-327 for offender specimen collection and drug testing services—a contract entirely unrelated to pharmaceutical products. The solicitation calls for staffing two collection sites in Plano and McKinney, operating an Interactive Voice Response system for randomized testing notifications, and conducting immunoassay screening with LC/MS/MS or GC/MS confirmation across approximately 25,031 annual tests. This code appears to show little relevant recent procurement activity aligned with its pharmaceutical classification.

The Collin County RFP, with an estimated contract value of $600,000 and a two-year initial term commencing September 1, 2026 with three optional one-year renewals, was due July 23, 2026 at 2:00 p.m., with an anticipated award date of August 10, 2026. The county reserves the right to award in whole or in part to multiple vendors and will evaluate proposals on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 points. Pricing must be submitted on a per-test basis across three service models—screening only, confirmation after screening, and screening with automatic confirmation of positives—with all costs including freight, delivery, insurance, and staffing embedded and no additional surcharges permitted. The successful vendor must maintain lab certification from SAMHSA, TX DPS, or CAP.